Metronidazole for BV commonly comes as an oral pill or vaginal gel. CDC lists both as recommended regimens. The best choice depends on tolerability, preference, pregnancy status, and clinician judgment.
TL;DR
Oral pill: systemic, twice daily for 7 days in the CDC recommended regimen.
Vaginal gel: local application once daily for 5 days in the CDC recommended regimen.
Gel usually causes fewer whole-body side effects.
Both require a prescription and clinician review.
Oral pill basics
The oral regimen is simple to prescribe and treats systemically. It may cause metallic taste, nausea, stomach upset, headache, or dizziness.
Vaginal gel basics
The gel is applied inside the vagina and usually has less systemic exposure. It may be preferred when oral metronidazole causes significant nausea or taste issues.
Alcohol guidance
MedlinePlus and many labels still warn against alcohol and propylene glycol during oral metronidazole and for at least 3 days after. CDC notes evidence for a true disulfiram-like reaction is not convincing, but patients should follow the prescribing clinician and pharmacy label.
Which works better?
CDC says no data directly compare oral and topical medications for BV in a way that proves one is superior for everyone. The practical decision is individualized.
Bidwell model
Bidwell Health offers a $45 online BV visit for eligible adults in 11 states. A licensed clinician reviews the intake 7 days a week, including weekends and sends metronidazole or clindamycin only when clinically appropriate. Medication cost is paid separately at the pharmacy.
Safety note: This page is educational and does not diagnose you. Online BV care is not the right fit for pregnancy with concerning symptoms, pelvic pain, fever, possible STI exposure needing testing, recurrent BV, or symptoms that do not fit BV. Those situations need in-person evaluation or lab testing.
BV is a bacterial imbalance, not a fungus. That’s why OTC yeast treatments don’t reliably help — and why the right medication matters.
BV more likely: thin discharge and a fishy odor (often stronger after sex), usually less intense itching.
Yeast more likely: significant itching/irritation and thicker white discharge, usually minimal odor.
UTI more likely: burning with urination and urgency/frequency without a primary change in vaginal discharge.
Metronidazole options (and what to expect)
Metronidazole is a first-line treatment for uncomplicated BV. It can be prescribed as a pill or vaginal gel; which one is best depends on your symptoms, side effects, and preference.
Timeline: many people notice improvement in odor/discharge within 2–3 days, with continued improvement through day 5–7.
If you’re not improving by day 3–4: reassess the diagnosis (yeast, trichomoniasis, dermatitis, or mixed infection).
Finish the course even if you feel better early — partial treatment can increase recurrence risk.
When online care is not appropriate
Online BV care is best for straightforward symptoms. You generally need in-person evaluation/testing if any of the following apply:
Pregnancy
Fever, significant pelvic pain, or severe symptoms
Recurrent BV or symptoms that return quickly after treatment
Genital sores, bleeding, or high STI risk
First-time symptoms where the diagnosis is uncertain
Why BV comes back (recurrence is common)
BV recurrence is frustratingly common. It’s not always about “not being clean” — it’s about vaginal pH, the microbiome, and re-shifts after treatment.
Microbiome rebound: even after antibiotics, BV-associated bacteria can re-establish.
pH disruption: semen and douching can raise vaginal pH and increase recurrence risk.
Mixed patterns: BV and yeast can alternate or overlap, especially after antibiotics.
How to reduce recurrence (practical, low-risk steps)
Avoid douching (strong evidence it increases BV risk).
Condom use can reduce pH disruption and may help some people with recurrence.
If BV keeps returning, ask about a longer-course or suppressive regimen rather than repeating short courses indefinitely.
How online BV treatment typically works (step-by-step)
You answer a structured intake focused on discharge/odor pattern and red flags.
A licensed clinician reviews the story and decides whether BV is the most likely diagnosis and whether online treatment is appropriate.
If appropriate, metronidazole (pill or gel) can be prescribed to your pharmacy.
If symptoms are atypical, severe, or recurrent, in-person testing is the safer next step.
How patients usually choose between pill and gel
Both oral metronidazole and vaginal metronidazole gel are commonly used BV options. The best fit often comes down to side effects, convenience, preference, and whether there are reasons to avoid one route.
Pill: systemic exposure, simpler for some people, but may cause nausea or metallic taste.
Gel: vaginal route, often less systemic exposure, but can be messy and may not fit every situation.
Neither without review: if symptoms suggest yeast, STI, pelvic infection, pregnancy-related concern, or recurrent disease.
What matters more than route
The diagnosis matters more than pill versus gel. If the symptom pattern is not BV, changing the metronidazole route will not fix the problem. If BV keeps returning, repeated short courses may not be the best long-term strategy.
Bidwell's BV intake can support a clinician decision about whether BV treatment is appropriate and which route may fit. The prescription decision stays with the clinician, and medication is sent to the patient's pharmacy only when appropriate.
Questions that help choose the route
A clinician may consider convenience, tolerance, prior response, and patient preference when choosing between oral and vaginal metronidazole. The right route is the one the patient can use correctly and safely.
Have you had nausea or metallic taste with oral metronidazole before?
Would a vaginal gel be difficult because of bleeding, discharge, or preference?
Are symptoms recurrent enough that a broader strategy is needed?
Patients often focus on which route is "stronger," but the better question is which route fits the diagnosis, safety profile, and ability to complete treatment.
Follow-up rules after BV treatment
The safest BV plan includes a clear follow-up threshold. Improvement should be noticeable within a few days, especially with odor and discharge. If symptoms do not improve, return quickly, or change character, the next step is diagnosis review rather than repeating the same medication automatically.
Follow up: no improvement by day 3-4, quick recurrence, or symptoms that feel different from prior BV.
Get tested: possible STI exposure, pregnancy concern, recurrent BV, or mixed yeast/BV symptoms.
Seek urgent care: fever, significant pelvic pain, severe illness, or concern for pelvic infection.
This follow-up language is part of the clinical value of the page. It helps patients understand when online BV care is enough and when the safer path is local testing or in-person evaluation.